Cellular Biomedicine Group (CBMG) Reports Q2, H1 2020 Financial Results and Business Highlights

PRNewswire/ — Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies …
( read original story …)